相关实验视频

Updated: Jul 5, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

塞图西马布作为转移性结肠直肠癌个性化向治疗的关键合作伙伴

Nadia Saoudi González^1,2, Javier Ros^1,2, Iosune Baraibar^1,2

¹Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.

|January 23, 2024

概括

向EGFR抗体Cetuximab提供了针对转移性结直肠癌 (mCRC) 的个性化治疗. 它在针对特定分子亚组的组合疗法中显示出前景,改善了mCRC患者的治疗结果.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

转移性结直肠癌 (mCRC) 提出了重大治疗挑战.
个性化医疗方法对于改善患者治疗结果至关重要.

研究的目的:

审查 cetuximab 在mCRC中的作用机制,特征和适应症.
强调 cetuximab 在针对特定的 mCRC 分子组的新型组合疗法中的作用.
讨论基于 cetuximab 的治疗方法对 mCRC 的不断变化的景观.

主要方法:

关于 cetuximab 在 mCRC 中的疗效和应用的文献综述.
临床试验数据的分析和分子子组向.
关于 cetuximab 在组合疗法中的作用的信息综合.

主要成果:

塞图西马布是一种有效的EGFR向mCRC的单克隆抗体.
它在特定的分子子组中显示出有效性,包括BRAF V600E,KRAS G12C和HER2改变的mCRC.
涉及塞图西马布的组合疗法显示出克服治疗耐药性的潜力.

结论:

塞图西马布是个性化针对性治疗mCRC的基石.
其与其他药物结合的战略使用扩大了治疗选择,并为耐药病例提供了希望.
目前正在进行的研究继续改进基于 cetuximab 的mCRC治疗策略.

关键词:

这就是BRAFV600600.在KRASG12C中使用.这就是 cetuximab 的意思.结肠直肠癌是什么意思个性化治疗个性化治疗

更多相关视频

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...